The Centers for Disease Control and Prevention (HHS) seeks applications for $175 million in grants through its Emerging Infections Program (CFDA Number: 93.317) (Funding Opportunity Number: CDC-RFA-CK17-1701).
Deadline: June 16.
The program supports local, state and national efforts to prevent, control and monitor the public health impact of emerging infectious diseases, such as Lyme Disease and various flu strains. State and local governments can use these funds for: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies and newly emerging issues. States receive the funding and then make subawards to localities.